Thai Hoang1, Hong Nguyen2, Ray W Shiraishi3, Mai Nguyen4, Trista Bingham3, Diep Nguyen4, Tam Nguyen4, Hao Duong5, Sheryl Lyss2, Hien Tran4. 1. Centers for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA. Electronic address: vph6@cdc.gov. 2. Centers for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA. 3. Centers for Diseases Control and Prevention, Division of Global HIV and TB, USA. 4. Vietnam Administration of HIV/AIDS Control, Viet Nam. 5. Centers for Diseases Control and Prevention, Division of Global HIV and TB, Atlanta, USA; The Partnership for Health Advancement in Vietnam (HAIVN), Viet Nam.
Abstract
BACKGROUND: Methadone maintenance treatment (MMT) is highly effective for reducing heroin use and HIV transmission among people who inject opioids. We sought to measure and understand factors associated with continued heroin use, a critical factor affecting treatment outcome among MMT patients in Vietnam. METHOD: We collected data from medical charts of a nationally representative sample of patients who were on MMT from May 2008 to December 2013. We selected 10 MMT clinics using probability proportional to size and 50 patients/clinic by systematic random sampling. Concurrent heroin use was defined by self-report/positive urine test recorded in patient charts during month 3, 6, 12, and 24 after MMT initiation. We used multivariable logistic regression to identify factors associated with concurrent heroin use over the first 24 months in treatment. FINDINGS: All clients used heroin at baseline; concurrent heroin use was 55% at month 3; 19%, 14.6% and 15.2% at month 6, 12, and 24, respectively. Having no family emotional/financial support at baseline versus having this support (AOR = 2.03; 95% confidence interval [CI] = 1.17-3.53); using heroin for <15 years versus ≥15 years at baseline (AOR = 1.55; 95% CI = 1.01-2.38); being HIV-infected/not on antiretroviral treatment (ART; AOR = 1.79; 95% CI = 1.07-2.98) or being HIV infected/on ART (AOR = 2.39; 95% CI = 1.61-3.55), versus not being HIV infected; baseline methamphetamine use versus non-use (AOR = 2.68; 95% CI = 1.08-6.65), were associated with increased odds of concurrent heroin use among patients. CONCLUSION: The association between concurrent heroin use among MMT patients and lack of family emotional/financial support, highlights the critical importance of these types of support for successful treatment. Association with shorter heroin use history suggests motivational enhancement may reduce concurrent heroin use. Living with HIV, whether on ART or not, is associated with increased concurrent heroin use and suggests safe injection commodities and education, and drug-drug interaction management, are needed for this subgroup. Though few MMT clients reported baseline methamphetamine use, its association with later heroin use suggests the need for effective methamphetamine use interventions. Published by Elsevier B.V.
BACKGROUND:Methadone maintenance treatment (MMT) is highly effective for reducing heroin use and HIV transmission among people who inject opioids. We sought to measure and understand factors associated with continued heroin use, a critical factor affecting treatment outcome among MMTpatients in Vietnam. METHOD: We collected data from medical charts of a nationally representative sample of patients who were on MMT from May 2008 to December 2013. We selected 10 MMT clinics using probability proportional to size and 50 patients/clinic by systematic random sampling. Concurrent heroin use was defined by self-report/positive urine test recorded in patient charts during month 3, 6, 12, and 24 after MMT initiation. We used multivariable logistic regression to identify factors associated with concurrent heroin use over the first 24 months in treatment. FINDINGS: All clients used heroin at baseline; concurrent heroin use was 55% at month 3; 19%, 14.6% and 15.2% at month 6, 12, and 24, respectively. Having no family emotional/financial support at baseline versus having this support (AOR = 2.03; 95% confidence interval [CI] = 1.17-3.53); using heroin for <15 years versus ≥15 years at baseline (AOR = 1.55; 95% CI = 1.01-2.38); being HIV-infected/not on antiretroviral treatment (ART; AOR = 1.79; 95% CI = 1.07-2.98) or being HIV infected/on ART (AOR = 2.39; 95% CI = 1.61-3.55), versus not being HIV infected; baseline methamphetamine use versus non-use (AOR = 2.68; 95% CI = 1.08-6.65), were associated with increased odds of concurrent heroin use among patients. CONCLUSION: The association between concurrent heroin use among MMTpatients and lack of family emotional/financial support, highlights the critical importance of these types of support for successful treatment. Association with shorter heroin use history suggests motivational enhancement may reduce concurrent heroin use. Living with HIV, whether on ART or not, is associated with increased concurrent heroin use and suggests safe injection commodities and education, and drug-drug interaction management, are needed for this subgroup. Though few MMT clients reported baseline methamphetamine use, its association with later heroin use suggests the need for effective methamphetamine use interventions. Published by Elsevier B.V.
Authors: S M Clarke; F M Mulcahy; J Tjia; H E Reynolds; S E Gibbons; M G Barry; D J Back Journal: Br J Clin Pharmacol Date: 2001-03 Impact factor: 4.335
Authors: Marcus Baumeister; Marc Vogel; Kenneth M Dürsteler-MacFarland; Urs Gerhard; Johannes Strasser; Marc Walter; Gerhard A Wiesbeck; Sylvie A Petitjean Journal: Subst Abuse Treat Prev Policy Date: 2014-12-04
Authors: Bach Xuan Tran; Arto Ohinmaa; Steve Mills; Anh Thuy Duong; Long Thanh Nguyen; Philip Jacobs; Stan Houston Journal: PLoS One Date: 2012-12-12 Impact factor: 3.240
Authors: Dana Button; Ryan Cook; Caroline King; Tong Thi Khuyen; Lynn Kunkel; Gavin Bart; Dinh Thanh Thuy; Diep Bich Nguyen; Christopher K Blazes; Le Minh Giang; P Todd Korthuis Journal: Int J Drug Policy Date: 2021-11-09
Authors: Kim A Hoffman; Le Minh Giang; P Todd Korthuis; Andrew Edsall; Dinh Thanh Thuy; Pham Phuong Mai; Nguyen Thu Hang; Tong Thi Khuyen; Nguyen Thu Trang; Lynn E Kunkel Journal: BMC Public Health Date: 2021-09-22 Impact factor: 4.135
Authors: Andrew Edsall; Thanh Thuy Thi Dinh; Pham Phuong Mai; Kim Hoffman; Hang T Nguyen; Tong Thi Khuyen; Nguyen Thu Trang; Gavin Bart; Le Minh Giang; P Todd Korthuis Journal: J Behav Health Serv Res Date: 2021-04 Impact factor: 1.505